Orionis will design molecular glues for targets chosen by Roche’s Genentech unit, with the latter responsible for taking over responsibility for any resulting candidates from the late ...

Aviv Regev, executive vice president and head of Genentech Research & Early Development (gRED) NVIDIA’s push into the life sciences sector has been rewarded by a wide-ranging deal with Roche’s ...

Roche unit Genentech in pact with Orionis for cancer therapies SA News Wed, May 21 Sarepta, Roche get U.K. feedback to continue dosing in Elevidys' Duchenne trial ...